pdufa.bio
Home › 2026 Clinical Trial Readout Calendar

2026 Clinical Trial Readout Calendar

By therapeutic area: oncology readouts · rare disease readouts

Page updated ·next FDA decision on the calendar ·Data as of Nov 5, 2026 9:00 PM ET

This page lists 181 expected clinical trial readouts covering November 2026 to December 2027. A further 132 readouts whose window has already passed are listed below with what we found: the sponsor's release where one exists, otherwise the date we last checked. These dates come from company guidance and ClinicalTrials.gov, so most are known only to a month or a quarter, and we publish them at that precision rather than guessing a day.

Upcoming Phase 1/2/3 data readouts: company, drug, indication, and the registered trial. Dates are estimated primary-completion windows from ClinicalTrials.gov, not fixed announcements: they shift. Tap any row for the trial record.
PDUFA datesTrial readoutsDevices
14Jun '2633Jul40Aug47Sep41Oct31Nov103Dec36Jan '2722Feb45Mar27Apr26May48Jun21Jul41Aug33Sep26Oct21Nov42Dec
Upcoming readouts per month (dated estimates; quarter/half-year-only items not charted).
Company-guided readouts

These 45 dates are not trial-registry estimates. Each one is timing the company itself stated in an SEC filing, and each row links to that filing so you can read the sentence it came from. Dates are shown at the precision the company used: a quarter stays a quarter rather than being rendered as a specific day it never named. Guidance that was vaguer than a quarter is not on this page at all.

GuidedTickerProgramCompanySource
Q4 2026ALNYelebsiran Alnylam Pharmaceuticals, Inc.10-K 2026-02-12
Q4 2026ATAIVLS-01 AtaiBeckley Inc.EX-99.1 2026-05-12
Q4 2026BMEABMF-650 Biomea Fusion, Inc.EX-99.1 2026-05-11
Q4 2026CMPXCTX-10726 Compass Therapeutics, Inc.EX-99.1 2026-05-05
Dec 2026CRISNCT07271667 Curis Inc10-Q 2026-05-13
Q4 2026ENTAEDP-978 Enanta Pharmaceuticals Inc424B5 2026-07-02
Q4 2026HELPHLP003 Cybin Inc.EX-99.1 2026-08-03
Q4 2026IPSCCNTY-813 Century Therapeutics, Inc.EX-99.1 2026-06-08
Q4 2026IVEVFlanifibranor Inventiva S.A.EX-99.2 2026-09-28
Q4 2026KYNBFG-3246 Kyntra Bio, Inc.10-Q 2026-05-12
Q4 2026LONAATH-1105 LeonaBio, Inc.EX-99.1 2026-05-07
Q4 2026MIRMAZURE-1 Mirum Pharmaceuticals, Inc.EX-99.1 2026-05-06
Q4 2026MTVADA-1726 MetaVia Inc.EX-99.1 2026-04-10
Q4 2026PCVXOPUS-1 Vaxcyte, Inc.EX-99.1 2026-05-06
Q4 2026RAPPRAP-219 Rapport Therapeutics, Inc.EX-99.1 2026-05-07
Q4 2026RGNXRGX-314 REGENXBIO Inc.EX-99.1 2026-06-29
Q4 2026SKYEnimacimab Skye Bioscience, Inc.10-Q 2026-05-11
Q4 2026SLGLSGT-610 Sol-Gel Technologies Ltd.EX-99.1 2026-05-28
Q4 2026SLSSLS009 SELLAS Life Sciences Group, Inc.EX-99.1 2026-05-12
Q4 2026SLSgalinpepimut-S (GPS) event-drivenSELLAS Life Sciences Group, Inc.EX-99.1 2026-05-12
Q4 2026SNDXSNDX-62122 Syndax Pharmaceuticals IncEX-99.1 2026-07-14
Q4 2026TRAXANB033 First Tracks Biotherapeutics, Inc.EX-99.1 2026-05-14
Q4 2026ZBIOZB021 Zenas BioPharma, Inc.EX-99.1 2026-05-13
Q1 2027AKTSAKY-1189 Aktis Oncology, Inc.EX-99.1 2026-05-11
Q1 2027CRBPCRB-701 Corbus Pharmaceuticals Holdings, Inc.10-Q 2026-05-12
Q1 2027DYNz-basivarsen (DYNE-101) Dyne Therapeutics, Inc.8-K 2026-09-29
Q1 2027MBRXAnnamycin Moleculin Biotech, Inc.EX-99.1 2026-09-29
Q1 2027NMRANMRA-511 Neumora Therapeutics, Inc.EX-99.1 2026-05-07
Q1 2027OCULHELIOS-3 Ocular Therapeutix, Inc10-Q 2026-05-05
Q1 2027QNCXLAM-001 Quince Therapeutics, Inc.EX-99.4 2026-07-30
Q1 2027TTRXGX-03 Turn Therapeutics Inc.EX-99.1 2026-10-07
Q2 2027IRDOPGx-BEST1 (AAV gene therapy) Opus Genetics, Inc.EX-99.1 2026-09-09
Q2 2027PROKREGEN-006 Prokidney Corp.EX-99.2 2026-05-15
2027-12-31ANLAN4035 (CEACAM5 ADC) Adlai Nortye Group Ltd.EX-99.1 2026-09-08
2027-12-31BIOABGE-102 (oral NLRP3 inhibitor) BioAge Labs, Inc.8-K 2026-10-02
Q4 2027EYPTDURAVYU EyePoint, Inc.EX-99.1 2026-08-17
2027-12-31GPCRACCG-2671 (oral amylin agonist) Structure Therapeutics Inc.EX-99.1 2026-09-08
Q4 2027IMAolevaprubart (IMG-007) ImageneBio, Inc.EX-99.1 2026-08-05
Q4 2027KLRSTH103 Kalaris Therapeutics, Inc.EX-99.2 2026-07-17
2027-12-31KRROKRRO-121 (RNA-editing oligo) Korro Bio, Inc.EX-99.1 2026-10-05
2027-12-31KZIApaxalisib KAZIA THERAPEUTICS LTDEX-99.2 2026-08-31
Q4 2027LSTAMAR002 LISATA THERAPEUTICS, INC.EX-99.2 2026-09-17
2027-12-31PCVXVAX-31 Vaxcyte, Inc.EX-99.2 2026-10-05
2027-12-31TRXBTRB-061 (TNFR2 agonist) TRex Bio, Inc.S-1 2026-09-18
2027-12-31TYRASURF303 Tyra Biosciences, Inc.EX-99.1 2026-05-13
Reported & confirmed: day-of stock reaction
Outcome and date confirmed against the company's own release (linked per row); reaction is the Polygon-adjusted close vs the prior close. Facts only, not investment advice.
MRK · 2026-08-19 ✓ positive
Intismeran autogene + Keytruda · day-of close reaction, confirmed against the company release
+12.6%
MRNA · 2026-08-19 ✓ positive
Intismeran autogene + Keytruda · day-of close reaction, confirmed against the company release
+177.0%
AMLX · 2026-08-18 ✓ positive
Avexitide (Ph3 LUCIDITY, PBH) · day-of close reaction, confirmed against the company release
+63.8%
ABCL · 2026-08-10 ✓ positive
ABCL635 · day-of close reaction, confirmed against the company release
+43.5%
TENX · 2026-08-10 primary endpoint not met
TNX-103 (oral levosimendan), Ph3 L · day-of close reaction, confirmed against the company release
-89.8%
MPLT · 2026-07-27 ✓ positive
ML-007C-MA, Ph2 ZEPHYR (schizophre · day-of close reaction, confirmed against the company release
-72.9%
DFTX · 2026-09-14 ✓ positive
DT120 · reported today; day-of close is logged after the market close
close pending
EVMN · 2026-09-09 ✗ negative
EVO756 · reported today; day-of close is logged after the market close
close pending
GPCR · 2026-09-08 ✓ positive
ACCG-2671 · reported today; day-of close is logged after the market close
close pending
IMMX · 2026-09-29 ✓ positive
NXC-201 · reported today; day-of close is logged after the market close
close pending
IRON · 2026-09-10 reported
DISC-3405 · reported today; day-of close is logged after the market close
close pending
KOD · 2026-09-28 ✓ positive
KSI-501 · day-of close reaction, confirmed against the company release
+178.0%
PHVS · 2026-09-08 ✓ positive
deucrictibant · day-of close reaction, confirmed against the company release
+7.3%
TECX · 2026-09-29 ✓ positive
TX2100 · day-of close reaction, confirmed against the company release
-0.7%
ALMS · 2026-09-01 reported
envudeucitinib · day-of close reaction, confirmed against the company release
-56.6%
Readout windows that have passed: what we found, and the stock move over the window
Each row states what we found for that readout: the sponsor's own results release where one exists (linked), the registry's status where the trial was terminated, or the date we last checked the sponsor's releases and ClinicalTrials.gov and found no topline. The figure is the stock's move across the estimated window (Polygon daily closes), not a statement about trial success. Methodology.
ABOS · Oct 2026
sabirnetug · Sponsor release 2026-10-30
-90%
ANNX · Oct 2026
Tanruprubart · No topline found as of 2026-11-05
no price data
BIIB · Oct 2026
Litifilimab · No topline found as of 2026-11-05
no price data
CLDX · Oct 2026
Barzolvolimab · Sponsor release 2026-09-22
no price data
EYPT · Oct 2026
EYP-1901 · No topline found as of 2026-11-05
no price data
ILMN · Oct 2026
18F-MFBG · No topline found as of 2026-11-05
no price data
IMVT · Oct 2026
IMVT-1402 · Sponsor release 2026-09-23
no price data
INCY · Oct 2026
Povorcitinib · No topline found as of 2026-11-05
no price data
MRK · Oct 2026
Pembrolizumab · No topline found as of 2026-11-05
no price data
OGN · Oct 2026
150μg CFA (Elonva®) at stimulation day (SD) 1 an · No topline found as of 2026-11-05
+1%
OLMA · Oct 2026
Palazestrant · No topline found as of 2026-11-05
-14%
PBYI · Oct 2026
neratinib · No topline found as of 2026-11-05
+9%
PFE · Oct 2026
Palbociclib · No topline found as of 2026-11-05
+7%
RCUS · Oct 2026
Zimberelimab · No topline found as of 2026-11-05
-23%
RYTM · Oct 2026
Setmelanotide · No topline found as of 2026-11-05
no price data
SNY · Oct 2026
Venglustat · No topline found as of 2026-11-05
no price data
SRPT · Oct 2026
Eteplirsen · No topline found as of 2026-11-05
no price data
VTRS · Oct 2026
Cenerimod · No topline found as of 2026-11-05
no price data
VYGR · Oct 2026
VY7523 · No topline found as of 2026-11-05
no price data
WVE · Oct 2026
WVE-210201 · No topline found as of 2026-11-05
no price data
ACRS · Sep 2026
A-101 · No topline found as of 2026-11-05
no price data
APGE · Sep 2026
APG777 · No topline found as of 2026-11-05
no price data
ARQT · Sep 2026
Topical Roflumilast · No topline found as of 2026-11-05
-5%
BHVN · Sep 2026
Taldefgrobep Alfa · No topline found as of 2026-11-05
-29%
BIIB · Sep 2026
Litifilimab · No topline found as of 2026-11-05
+1%
CCCC · Sep 2026
Cemsidomide · No topline found as of 2026-11-05
-32%
CGEM · Sep 2026
CLN-081 · No topline found as of 2026-11-05
-29%
CSLLY · Sep 2026
Recombinant Single-Chain Factor Viii · No topline found as of 2026-11-05
no price data
EXEL · Sep 2026
Cabozantinib · No topline found as of 2026-11-05
no price data
GILD · Sep 2026
Sacituzumab Govitecan · No topline found as of 2026-11-05
no price data
GOSS · Sep 2026
Seralutinib · Terminated per ClinicalTrials.gov
no price data
IBRX · Sep 2026
ALT-803 · No topline found as of 2026-11-05
no price data
IMMP · Sep 2026
eftilagimod alfa · No topline found as of 2026-11-05
no price data
IVA · Sep 2026
IVA337 · No topline found as of 2026-11-05
no price data
KPTI · Sep 2026
Selinexor · No topline found as of 2026-11-05
no price data
MLTX · Sep 2026
Sonelokimab · Sponsor release 2026-08-10
-30%
MRK · Sep 2026
Pembrolizumab · No topline found as of 2026-11-05
-7%
PHAT · Sep 2026
Vonoprazan · No topline found as of 2026-11-05
-23%
SLN · Sep 2026
SLN124 · No topline found as of 2026-11-05
-27%
SUPN · Sep 2026
SPN-812 · No topline found as of 2026-11-05
-5%
VERA · Sep 2026
Atacicept · No topline found as of 2026-11-05
no price data
VIR · Sep 2026
Tobevibart · No topline found as of 2026-11-05
no price data
VNDA · Sep 2026
VSJ-110 · No topline found as of 2026-11-05
no price data
WVE · Sep 2026
WVE-210201 · No topline found as of 2026-11-05
no price data
ZURA · Sep 2026
Tibulizumab · No topline found as of 2026-11-05
no price data
AARD · Sep 2026
ARD-101 readout · No topline found as of 2026-11-05
no price data
ALZN · Sep 2026
AL001 Phase II topline (bipolar disorder) · No topline found as of 2026-11-05
no price data
BOLT · Sep 2026
BDC-4182 readout · No topline found as of 2026-11-05
no price data
BSEM · Sep 2026
Clinical readout · Window passed; not yet checked
-33%
MNKD · Sep 2026
MNKD-201 readout · No topline found as of 2026-11-05
-9%
MSLE · Sep 2026
Clinical readout · Window passed; not yet checked
-19%
OCGN · Sep 2026
OCU400 readout · No topline found as of 2026-11-05
-26%
PMN · Sep 2026
PMN310 readout · No topline found as of 2026-11-05
-36%
PPBT · Sep 2026
IM1305 readout · No topline found as of 2026-11-05
no price data
ROIV · Sep 2026
brepocitinib readout · Sponsor release 2026-10-21
no price data
SCYX · Sep 2026
SCY-247 readout · No topline found as of 2026-11-05
no price data
STTK · Sep 2026
SL-846 readout · No topline found as of 2026-11-05
no price data
SYRE · Sep 2026
SPY001 readout · No topline found as of 2026-11-05
no price data
VKTX · Sep 2026
VANQUISH-2 Phase 3 (VK2735) topline · Sponsor release 2026-09-22
no price data
VTGN · Sep 2026
fasedienol readout · Sponsor release 2026-09-22
no price data
WHWK · Sep 2026
HWK-007 readout · No topline found as of 2026-11-05
no price data
XENE · Sep 2026
XEN1701 readout · No topline found as of 2026-11-05
-43%
AKBA · Aug 2026
Vadadustat · Sponsor release 2026-11-05
-24%
APGE · Aug 2026
APG777 · No topline found as of 2026-11-05
+1%
ARDX · Aug 2026
Tenapanor · No topline found as of 2026-11-05
-25%
BIVI · Aug 2026
NE3107 · No topline found as of 2026-11-05
+46%
BMRN · Aug 2026
Vosoritide · Sponsor release 2026-09-09
no price data
CLRB · Aug 2026
NOV-002 · No topline found as of 2026-11-05
no price data
IVVD · Aug 2026
VYD2311 · Sponsor release 2026-09-29
no price data
MANE · Aug 2026
VDPHL01 · Sponsor release 2026-10-18
no price data
MRK · Aug 2026
Ensifentrine · No topline found as of 2026-11-05
no price data
NVO · Aug 2026
Semaglutide · No topline found as of 2026-11-05
no price data
TMO · Aug 2026
MK-7240 · No topline found as of 2026-11-05
no price data
VSTM · Aug 2026
avutometinib · No topline found as of 2026-11-05
no price data
AMGN · Jul 2026
Tezepelumab · No topline found as of 2026-11-05
+15%
ARDX · Jul 2026
Tenapanor · No topline found as of 2026-11-05
-20%
AXSM · Jul 2026
AXS-14 · No topline found as of 2026-11-05
-11%
CRDF · Jul 2026
Onvansertib · No topline found as of 2026-11-05
-21%
ELVN · Jul 2026
ELVN-002 · No topline found as of 2026-11-05
+23%
EXEL · Jul 2026
Cabozantinib · No topline found as of 2026-11-05
no price data
EYPT · Jul 2026
EYP-1901 · No topline found as of 2026-11-05
no price data
GRFS · Jul 2026
ALPHA-1 MP · No topline found as of 2026-11-05
no price data
ILMN · Jul 2026
18F-MFBG · No topline found as of 2026-11-05
no price data
IOVA · Jul 2026
Lifileucel plus Pembrolizumab · No topline found as of 2026-11-05
no price data
JAZZ · Jul 2026
Lurbinectedin · No topline found as of 2026-11-05
no price data
JSPR · Jul 2026
Briquilimab · Terminated per ClinicalTrials.gov
no price data
JSPR · Jul 2026
Briquilimab · No topline found as of 2026-11-05
no price data
LTRN · Jul 2026
Tavocept(BNP7787) in combination with cisplatin · No topline found as of 2026-11-05
-24%
OGN · Jul 2026
150μg CFA (Elonva®) at stimulation day (SD) 1 an · No topline found as of 2026-11-05
+1%
PTCT · Jul 2026
PTC923 · No topline found as of 2026-11-05
-16%
RARE · Jul 2026
GTX-102 · No topline found as of 2026-11-05
-12%
SMMT · Jul 2026
Ivonescimab · No topline found as of 2026-11-05
-5%
XNCR · Jul 2026
XMAB20717 · No topline found as of 2026-11-05
no price data
AGMB · Jun 2026
AGMB-129 · No topline found as of 2026-11-05
no price data
ARDX · Jun 2026
Tenapanor · No topline found as of 2026-11-05
no price data
AVIR · Jun 2026
Bemnifosbuvir-Ruzasvir · No topline found as of 2026-11-05
no price data
BMY · Jun 2026
Nivolumab · No topline found as of 2026-11-05
no price data
CELC · Jun 2026
Gedatolisib · No topline found as of 2026-11-05
no price data
CLLS · Jun 2026
UCART22 · No topline found as of 2026-11-05
no price data
FTH · Jun 2026
SNS-101 · No topline found as of 2026-11-05
no price data
JAZZ · Jun 2026
Zanidatamab · No topline found as of 2026-11-05
+3%
LEGN · Jun 2026
LCAR-B38M CAR-T Cell · No topline found as of 2026-11-05
-5%
SION · Jun 2026
SION-719 · No topline found as of 2026-11-05
+1%
TLX · Jun 2026
177Lu-TLX591 · No topline found as of 2026-11-05
+27%
TRVI · Jun 2026
Nalbuphine ER Tablets · No topline found as of 2026-11-05
+25%
ALEC · May 2026
AL001 · Terminated per ClinicalTrials.gov
no price data
KPTI · May 2026
Selinexor · No topline found as of 2026-11-05
no price data
MLTX · May 2026
Sonelokimab · Sponsor release 2026-08-10
no price data
SNGX · May 2026
Hypericin · Terminated per ClinicalTrials.gov
no price data
CALC · Apr 2026
CM4620 · Terminated per ClinicalTrials.gov
no price data
CERS · Apr 2026
S-303 Treated Red Blood Cells · No topline found as of 2026-11-05
no price data
ELTX · Apr 2026
ELI-002 7P · No topline found as of 2026-11-05
no price data
HOWL · Apr 2026
WTX-330 · No topline found as of 2026-11-05
no price data
IMMP · Apr 2026
eftilagimod alfa · Terminated per ClinicalTrials.gov
+23%
ANIP · Mar 2026
Yutiq · No topline found as of 2026-11-05
+3%
IXHL · May 2025
IHL-42X Low Dose · No topline found as of 2026-11-05
-69%
HUMA · Sep 2023
Human Acellular Vessel · Results posted on ClinicalTrials.gov 2025-03-12
no price data
November 2026
ATOS · Nov 2026 (est.)
Z-Endoxifen: Breast Neoplasms
Awaiting data
APGE · Nov 2026 (est.)
APG777: Atopic Dermatitis
Awaiting data
ERAS · Nov 2026 (est.)
Naporafenib: Advanced or Metastatic Solid Tumors
Awaiting data
IMUX · Nov 2026 (est.)
IMU-838 tablets: Multiple Sclerosis
Awaiting dataupdated 4mo ago
IOVA · Nov 2026 (est.)
Lifileucel plus Pembrolizumab: Metastatic Melanoma
Awaiting dataupdated 10mo ago
ONC · Nov 2026 (est.)
BGB-11417: Relapsed/Refractory Multiple Myeloma
TYRA · Nov 2026 (est.)
TYRA-300: Locally Advanced Urothelial Carcinoma
Awaiting dataupdated 5mo ago
VIR · Nov 2026 (est.)
Bulevirtide: Viral Hepatitis
Awaiting dataupdated 5mo ago
VXRT · Nov 2026 (est.)
VXA-COV2-3.3: SARS-CoV2
Awaiting data
ZURA · Nov 2026 (est.)
Tibulizumab: Hidradenitis Suppurativa (HS)
Awaiting data
ELTX · Nov 2026 (est.)
ELI-002 7P: Pancreatic Ductal Adenocarcinoma
Awaiting data
CRDF · Nov 2026 (est.)
Onvansertib: Metastatic Colorectal Cancer
Awaiting data
BYSI · Nov 2026 (est.)
Docetaxel + Plinabulin: Multiple Myeloma
Awaiting dataupdated 6mo ago
CGEM · Nov 2026 (est.)
CLN-081: NHL
Awaiting dataupdated 26mo ago
PHAR · Nov 2026 (est.)
Leniolisib: APDS
Awaiting data
SNY · Nov 2026 (est.)
Rilzabrutinib: Immune Thrombocytopenia
December 2026
CNTA · Dec 2026 (est.)
cleminorexton: Narcolepsy Type 1
BEAM · Dec 2026 (est.)
BEAM-302: Lymphoblastic Lymphoma
Awaiting dataupdated 18mo ago
BIIB · Dec 2026 (est.)
Felzartamab: Antibody-mediated Rejection
Awaiting data
BMY · Dec 2026 (est.)
Nivolumab: Non Small Cell Lung Cancer
CMPX · Dec 2026 (est.)
CTX-009: Biliary Tract Cancer
Awaiting data
CORT · Dec 2026 (est.)
Relacorilant: Cushing Syndrome
Awaiting data
BCDA · Dec 2026 (est.)
Autologous cell therapy: Heart Failure, Systolic
Awaiting dataupdated 7mo ago
AGEN · Dec 2026 (est.)
Balstilimab: Refractory Metastatic Colorectal Cancer
Awaiting dataupdated 8mo ago
ALMS · Dec 2026 (est.)
Open-Label Envudeucitinib: Plaque Psoriasis
Awaiting data
APGE · Dec 2026 (est.)
APG777: Atopic Dermatitis
Awaiting data
AVIR · Dec 2026 (est.)
Bemnifosbuvir-Ruzasvir: HEPATITIS C VIRUS CHRONIC INFECTION
Awaiting data
MDGL · Dec 2026 (est.)
Resmetirom: NASH
Awaiting data
MRK · Dec 2026 (est.)
Pembrolizumab: Squamous Cell Cancer of Head and Neck
ONC · Dec 2026 (est.)
Zanubrutinib: Waldenstrom Macroglobulinemia
PBYI · Dec 2026 (est.)
neratinib: Breast Cancer
Awaiting data
PFE · Dec 2026 (est.)
Elranatamab: Multiple Myeloma
PHAT · Dec 2026 (est.)
Vonoprazan: Eosinophilic Esophagitis
Awaiting data
RGNX · Dec 2026 (est.)
Ranibizumab: AMD
Awaiting data
RNAC · Dec 2026 (est.)
Decartes-08: Systemic Lupus Erythematosus (SLE)
Awaiting data
MANE · Dec 2026 (est.)
VDPHL01: Androgenetic Alopecia
Awaiting dataupdated 4mo ago
LXEO · Dec 2026 (est.)
LX1001: Arrhythmogenic Cardiomyopathy
Awaiting dataupdated 8mo ago
GOSS · Dec 2026 (est.)
Seralutinib: Pulmonary Arterial Hypertension
Awaiting data
INO · Dec 2026 (est.)
VGX-3100: BRCA1/2 Mutation
Awaiting dataupdated 4mo ago
IONS · Dec 2026 (est.)
Donidalorsen: Hereditary Angioedema
Awaiting dataupdated 7mo ago
IXHL · Dec 2026 (est.)
IHL-42X Low Dose: Obstructive Sleep Apnea
Awaiting dataupdated 14mo ago
KPTI · Dec 2026 (est.)
Rituximab: Relapsed/Refractory Diffuse Large B-cell Lymphoma
Awaiting data
TRAW · Dec 2026 (est.)
rigosertib: Influenza
Awaiting data
SNDX · Dec 2026 (est.)
Revumenib: Leukemia
XNCR · Dec 2026 (est.)
XMAB20717: Biliary Tract Cancer
Awaiting dataupdated 9mo ago
PFE · Dec 2026 (est.)
Mevrometostat: Metastatic Castration-Resistant Prostate Cancer
CRDF · Dec 2026 (est.)
Onvansertib: Breast Cancer
Awaiting dataupdated 4mo ago
SNY · Dec 2026 (est.)
Rilzabrutinib: Focal Segmental Glomerulosclerosis
SUPN · Dec 2026 (est.)
BIS-001: Focal Impaired Awareness Seizures
Awaiting dataupdated 47mo ago
ARVN · Dec 2026 (est.)
ARV-471: Breast Cancer
Awaiting dataupdated 5mo ago
MNOV · Dec 2026 (est.)
MN-166: Diabetes Mellitus, Type 2
Awaiting dataupdated 5mo ago
PFE · Dec 2026 (est.)
Palbociclib: Breast Cancer
VIR · Dec 2026 (est.)
Tobevibart: Viral Hepatitis
Awaiting data
ACTU · Dec 2026 (est.)
Losartan: Pancreatic Adenocarcinoma
Awaiting data
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine: Chronic Lymphocytic Leukemia
Awaiting dataupdated 9mo ago
ARVN · Dec 2026 (est.)
ARV-471: Breast Cancer
Awaiting data
NVO · Dec 2026 (est.)
Semaglutide: Intestinal Mucositis
INSM · Dec 2026 (est.)
Treprostinil Palmitil Inhalation Powder: Pulmonary Arterial Hypertension
Awaiting data
INO · Dec 2026 (est.)
VGX-3100: Glioblastoma
Awaiting data
H2 2026 (est.)
QTTB · H2 2026
bempikibart: Alopecia Areata
FDMT · H2 2026
4D-150 IVT: Macular Neovascularization Secondary to Age-Related Macular Degeneration
NTLA · H2 2026
NTLA-2002: Hereditary Angioedema
PCVX · H2 2026
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
PHVS · H2 2026
deucrictibant: Hereditary Angioedema
SION · H2 2026
SION-719: Cystic Fibrosis (CF)
ZNTL · H2 2026
Investigator's choice of Chemotherapy: Ovarian Cancer
AURA · H2 2026
Bel-sar: Choroidal Melanoma
SABS · H2 2026
SAB-142
KPTI · H2 2026
EX-99
ANRO · H2 2026
EX-99
VRDN · H2 2026
VRDN-008
ADCT · H2 2026
rituximab
NGNE · H2 2026
NGN-401
Q4 2026 (est.)
CLDX · Q4 2026
Barzolvolimab: Chronic Inducible Urticaria
RGNX · Q4 2026
Ranibizumab: AMD
IRON · Q4 2026
DISC-1459: Erythropoietic Protoporphyria
HELP · Q4 2026
CYB003: Major Depressive Disorder
ATAI · Q4 2026
BPL-003
January 2027
ELVN · Jan 2027 (est.)
ELVN-002: HER2-positive Breast Cancer
Awaiting dataupdated 7mo ago
EXEL · Jan 2027 (est.)
Cabozantinib: Germ Cell Tumor
Awaiting dataupdated 5mo ago
PCVX · Jan 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
RARE · Jan 2027 (est.)
Setrusumab: Osteogenesis Imperfecta
Awaiting data
SIGA · Jan 2027 (est.)
Tecovirimat Oral Capsule: Smallpox
Awaiting data
CADL · Jan 2027 (est.)
Aglatimagene Besadenovec: Malignant Glioma of Brain
Awaiting dataupdated 4mo ago
BMY · Jan 2027 (est.)
Nivolumab: Hodgkin Lymphoma
REGN · Jan 2027 (est.)
Odronextamab: Follicular Lymphoma
OCUL · Jan 2027 (est.)
Otx-Tki: Neovascular Age-related Macular Degeneration
Awaiting dataupdated 12mo ago
GILD · Jan 2027 (est.)
MK-3475: Carcinoma, Non-Small-Cell Lung
IDYA · Jan 2027 (est.)
Darovasertib: Metastatic Uveal Melanoma
Awaiting dataupdated 4mo ago
APLM · Jan 2027 (est.)
Uproleselan: Metastatic Non Small Cell Lung Cancer
Awaiting dataupdated 5mo ago
February 2027
SNDX · Feb 2027 (est.)
Revumenib: Acute Myeloid Leukemias
Awaiting data
MRK · Feb 2027 (est.)
Pembrolizumab: Triple Negative Breast Cancer
KYTX · Feb 2027 (est.)
Standard of Care Treatment: Idiopathic Inflammatory Myopathies
Awaiting dataupdated 4mo ago
MLTX · Feb 2027 (est.)
Sonelokimab: Arthritis, Psoriatic
Awaiting data
OCGN · Feb 2027 (est.)
OCU410ST: Retinitis Pigmentosa
Awaiting dataupdated 4mo ago
AZN · Feb 2027 (est.)
R-Chop: Diffuse Large B-Cell Lymphoma
March 2027
NUVB · Mar 2027 (est.)
safusidenib: Advanced Solid Tumor
Awaiting dataupdated 5mo ago
OCGN · Mar 2027 (est.)
OCU410ST: Retinitis Pigmentosa
Awaiting dataupdated 11mo ago
ONC · Mar 2027 (est.)
Zanubrutinib: Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
Awaiting data
PCVX · Mar 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
AGIO · Mar 2027 (est.)
Mitapivat: Chondrosarcoma
Awaiting data
IPHA · Mar 2027 (est.)
Monalizumab: Metastatic Cancer
Awaiting data
MDGL · Mar 2027 (est.)
Resmetirom: Non-Alcoholic Fatty Liver Disease
Awaiting data
IONS · Mar 2027 (est.)
Olezarsen: Severe Hypertriglyceridemia
Awaiting dataupdated 7mo ago
COGT · Mar 2027 (est.)
CGT9486: Intrahepatic Cholangiocarcinoma (Icc)
Awaiting data
DNLI · Mar 2027 (est.)
BIIB122: Parkinson Disease
Awaiting data
TSHA · Mar 2027 (est.)
TSHA-101: Infantile GM2 Gangliosidosis (Disorder)
Awaiting dataupdated 38mo ago
GILD · Mar 2027 (est.)
Sacituzumab Govitecan: HER2-negative Breast Cancer
CLDX · Mar 2027 (est.)
Barzolvolimab: Glioblastoma
Awaiting data
April 2027
CGTX · Apr 2027 (est.)
Dextromethorphan-Bupropion: Early Alzheimer's Disease
Awaiting dataupdated 9mo ago
KPTI · Apr 2027 (est.)
Selinexor: Multiple Myeloma
Awaiting data
KYTX · Apr 2027 (est.)
Standard of Care Treatment: Multiple Sclerosis, Primary Progressive
Awaiting dataupdated 18mo ago
MNOV · Apr 2027 (est.)
MN-166: Amyotrophic Lateral Sclerosis
Awaiting dataupdated 4mo ago
CLDX · Apr 2027 (est.)
Barzolvolimab: Malignant Epithelial Neoplasms
Awaiting data
IOVA · Apr 2027 (est.)
Lifileucel plus Pembrolizumab: Bone Sarcoma
Awaiting data
IDYA · Apr 2027 (est.)
Darovasertib: Uveal Melanoma
Awaiting data
NBTX · Apr 2027 (est.)
NBTXR3: Radiotherapy
Awaiting dataupdated 8mo ago
NVS · Apr 2027 (est.)
Iptacopan: Generalized Myasthenia Gravis
REGN · Apr 2027 (est.)
Cemiplimab: Colon Cancer
AIM · Apr 2027 (est.)
Ampligen: Prostate Adenocarcinoma
Awaiting data
May 2027
TNGX · May 2027 (est.)
S095035: MTAP-deleted Solid Tumors
Awaiting data
VYGR · May 2027 (est.)
VY7523: Alzheimer's Disease (AD)
Awaiting dataupdated 7mo ago
REGN · May 2027 (est.)
Cemiplimab: Recurrent Ovarian Cancer
REGN · May 2027 (est.)
Cemiplimab: Non-Small Cell Lung Cancer
FDMT · May 2027 (est.)
4D-150 IVT: Choroideremia
Awaiting dataupdated 13mo ago
MBX · May 2027 (est.)
MBX 2109: Hypoparathyroidism
Awaiting dataupdated 8mo ago
June 2027
AVLN · Jun 2027 (est.)
AP01: Pulmonary Fibrosis
Awaiting data
KYMR · Jun 2027 (est.)
KT-621: Atopic Dermatitis
Awaiting data
FDMT · Jun 2027 (est.)
4D-150 IVT: Macular Neovascularization Secondary to Age-Related Macular Degeneration
Awaiting data
FTH · Jun 2027 (est.)
SNS-101: Solid Tumor, Adult
Awaiting dataupdated 10mo ago
IMMP · Jun 2027 (est.)
eftilagimod alfa: Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Awaiting data
IONS · Jun 2027 (est.)
Olezarsen: Familial Chylomicronemia Syndrome
Awaiting dataupdated 7mo ago
JAZZ · Jun 2027 (est.)
CPX-351: Acute Myeloid Leukemia
Awaiting dataupdated 11mo ago
KYTX · Jun 2027 (est.)
Standard of Care Treatment: Rheumatoid Arthritis
Awaiting dataupdated 4mo ago
NMRA · Jun 2027 (est.)
NMRA-335140: Major Depressive Disorder
Awaiting data
NVS · Jun 2027 (est.)
Remibrutinib: Hidradenitis Suppurativa
BLTE · Jun 2027 (est.)
Tinlarebant: Geographic Atrophy
Awaiting dataupdated 6mo ago
INDP · Jun 2027 (est.)
Decoy20: Solid Tumor, Adult
Awaiting dataupdated 5mo ago
July 2027
MESO · Jul 2027 (est.)
Rexlemestrocel-L: Degenerative Disc Disease
Awaiting data
VKTX · Jul 2027 (est.)
VK2735: Weight Loss
Awaiting dataupdated 7mo ago
ONCY · Jul 2027 (est.)
REOLYSIN: Anal Cancer Metastatic
Awaiting data
AMGN · Jul 2027 (est.)
ABP 938: Neovascular Age-related Macular Degeneration
August 2027
ARTV · Aug 2027 (est.)
AB-101: Lupus Nephritis - WHO Class III
Awaiting dataupdated 7mo ago
ASND · Aug 2027 (est.)
TransCon CNP: Advanced Solid Tumor
Awaiting dataupdated 4mo ago
RARE · Aug 2027 (est.)
Triheptanoin: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Awaiting data
NVCR · Aug 2027 (est.)
Temozolomide: Adenocarcinoma of Lung
Awaiting data
September 2027
BHVN · Sep 2027 (est.)
BHV-1300: Graves Disease
CHRS · Sep 2027 (est.)
CHS-1420: Hepatocellular Carcinoma
Awaiting data
CSTL · Sep 2027 (est.)
FCX-007: Dystrophic Epidermolysis Bullosa
Awaiting data
HUMA · Sep 2027 (est.)
Human Acellular Vessel: Trauma
Awaiting dataupdated 32mo ago
IMVT · Sep 2027 (est.)
IMVT-1402: Rheumatoid Arthritis
Awaiting data
TLSI · Sep 2027 (est.)
Pembrolizumab: Locally Advanced Pancreatic Adenocarcinoma
Awaiting dataupdated 12mo ago
UPB · Sep 2027 (est.)
Verekitug: Severe Asthma
Awaiting data
AGEN · Sep 2027 (est.)
Botensilimab: Metastatic Colorectal Cancer
Awaiting dataupdated 10mo ago
INCY · Sep 2027 (est.)
Corticosteroids: Chronic Graft-versus-host-disease
CNTA · Sep 2027 (est.)
cleminorexton: Narcolepsy Type 1
IVA · Sep 2027 (est.)
IVA337: NASH - Nonalcoholic Steatohepatitis
Awaiting data
MAIA · Sep 2027 (est.)
6-Thio-2'-Deoxyguanosine: Carcinoma, Non-Small-Cell Lung
Awaiting data
VNDA · Sep 2027 (est.)
Tradipitant: Motion Sickness
Awaiting data
October 2027
LLY · Oct 2027 (est.)
Tirzepatide: Obesity
OGN · Oct 2027 (est.)
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5: Esophagogastric Adenocarcinoma
Awaiting data
ONC · Oct 2027 (est.)
Zanubrutinib: Primary Membranous Nephropathy
Awaiting data
TARS · Oct 2027 (est.)
TP-03: Lyme Disease
Awaiting data
MRK · Oct 2027 (est.)
MK-8527: Human Immunodeficiency Virus (HIV)
November 2027
CRNX · Nov 2027 (est.)
Atumelnant: Congenital Adrenal Hyperplasia
ONC · Nov 2027 (est.)
BGB-3111: B-cell Malignancies
Awaiting dataupdated 8mo ago
REGN · Nov 2027 (est.)
Cemdisiran: Age-related Macular Degeneration (AMD)
MYGN · Nov 2027 (est.)
Niraparib: Solid Tumor
Awaiting dataupdated 8mo ago
ARVN · Nov 2027 (est.)
ARV-471: KRAS G12D Mutation
Awaiting data
December 2027
RARE · Dec 2027 (est.)
Triheptanoin: Medium-chain Acyl-CoA Dehydrogenase Deficiency
ANVS · Dec 2027 (est.)
buntanetap/posiphen: Early Alzheimers Disease
Awaiting data
ADAG · Dec 2027 (est.)
ADG106: HER2-negative Breast Cancer
Awaiting dataupdated 11mo ago
GOSS · Dec 2027 (est.)
Seralutinib: Pulmonary Arterial Hypertension
Awaiting data
INTS · Dec 2027 (est.)
INT230-6: Sarcoma,Soft Tissue
Awaiting dataupdated 11mo ago
LEGN · Dec 2027 (est.)
LCAR-B38M CAR-T Cell: Gastric Cancer
Awaiting dataupdated 7mo ago
LLY · Dec 2027 (est.)
Mirikizumab: Crohn's Disease
OTLK · Dec 2027 (est.)
bevacizumab: Age-Related Macular Degeneration
Awaiting data
PCVX · Dec 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
H1 2027 (est.)
SPTX · H1 2027
SPT-300: Major Depressive Disorder (MDD)
· H1 2027
RPT904: Ig-E Mediated Food Allergy
H2 2027 (est.)
AVLN · H2 2027
AP01: Pulmonary Fibrosis
728 upcoming readouts. Source: ClinicalTrials.gov primary-completion estimates (month precision). Readout timing is not a guaranteed announcement date.

Questions

How many clinical trial readouts are tracked?

209 expected readouts are on the calendar as of November 5, 2026, each with its company-guided window and source.

Does pdufa.bio predict readout outcomes?

No. We publish dates, trial designs and measured stock reactions, each linked to its source; we do not publish outcome predictions or approval probabilities.

What is a readout?

The date a clinical trial's results become public, usually announced by the sponsor; unlike a PDUFA date it is an estimate until the company fixes it.